A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE
Condition(s):Venous Thromboembolism; Deep Venous Thrombosis; Pulmonary EmbolismLast Updated:January 19, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):Venous Thromboembolism; Deep Venous Thrombosis; Pulmonary EmbolismLast Updated:January 19, 2024Recruiting
Condition(s):Venous ThromboembolismLast Updated:January 24, 2024Recruiting
Condition(s):Recurrent Spontaneous AbortionLast Updated:May 26, 2023Recruiting
Condition(s):Anticoagulant; Venous Thromboembolism; Prophylaxis; TreatmentLast Updated:August 31, 2023Recruiting
Condition(s):Deep Vein Thrombosis; Post Thrombotic SyndromeLast Updated:June 18, 2023Recruiting
Condition(s):Critical Illness; ThrombosisLast Updated:September 28, 2023Recruiting
Condition(s):Venous ThromboembolismLast Updated:April 5, 2023Recruiting
Condition(s):Acute Kidney Injury; Renal Replacement Therapy; AnticoagulantsLast Updated:November 22, 2023Recruiting
Condition(s):Colorectal Cancer Metastatic; ThromboembolismLast Updated:February 23, 2024Recruiting
Condition(s):Epithelial Ovarian CancerLast Updated:January 25, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.